TBRA Overview
Upcoming Projects (TBRA)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (TBRA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (TBRA)
-
Allergan (AGN) Strengthens Liver Disease Portfolio in Agreement to Acquire Tobira Therapeutics (TBRA) for ~$1.695 Billion
Tickers: AGN, TBRA
Occurred on: Sep 20, 2016 -
Phase 2b CENTAUR study primary endpoint expected to be announced in the third quarter of 2016
Ticker: TBRA
Occurred on: Aug 09, 2016 -
Tobira's Cenicriviroc Reduces Inflammation and Fibrosis in Animal Models of Chronic Liver and Kidney Disease Including NASH
Ticker: TBRA
Occurred on: Jun 27, 2016 -
Tobira's Cenicriviroc Shown to Reduce Liver Injury in Independent Research Published in the Journal Hepatology
Ticker: TBRA
Occurred on: Jun 15, 2016 -
Tobira Therapeutics Announces Publication of Phase 1 Study Results Showing Cenicriviroc Safety in Cirrhotic Patients
Ticker: TBRA
Occurred on: May 13, 2016 -
Top-line 12-week interim analysis from ORION Phase 2a trial of Cenicriviroc is expected in the second quarter of 2016
Ticker: TBRA
Occurred on: May 02, 2016
Strategic Initiatives (TBRA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
